NCT00003808 2023-06-22
Theophylline in Treating Patients With In Situ, Stage I, or Stage II Chronic Lymphocytic Leukemia
Eastern Cooperative Oncology Group
Phase 2 Completed
Eastern Cooperative Oncology Group
Canadian Cancer Trials Group
University of Bergen
Janssen Research & Development, LLC